Rigel Pharmaceuticals (RIGL US)

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.